Excited to publish findings on PT-112's mechanism in prostate cancer cells, related to Phase 2 clinical development of PT-112 in patients with mCRPC. Thank you to my co-authors for their support and collaboration on this work!
rdcu.be/dWI8i
#oncologyresearch